Meihua International Medical Technologies
MHUA
MHUA was delisted on the 8th of December, 2025.
9 hedge funds and large institutions have $87.7K invested in Meihua International Medical Technologies in 2024 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 0 increasing their positions, 3 reducing their positions, and 3 closing their positions.
67% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 3
29% more funds holding
Funds holding: 7 → 9 (+2)
0.09% less ownership
Funds ownership: 0.1% → 0.01% (-0.09%)
97% less capital invested
Capital invested by funds: $2.53M → $87.7K (-$2.44M)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
+$25.4K |
| 2 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$21.4K |
| 3 |
HF
HRT Financial
New York
|
+$20.5K |
| 4 |
Two Sigma Investments
New York
|
+$18.6K |
| 5 |
Jane Street
New York
|
+$15.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AFM
Anson Funds Management
Dallas,
Texas
|
-$2.31M |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$41.3K |
| 3 |
MG
Marex Group
London,
|
-$25.5K |
| 4 |
Renaissance Technologies
New York
|
-$13.5K |
| 5 |
TSS
Two Sigma Securities
New York
|
-$8.46K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
UBS Group
Zurich,
Switzerland
| $21.5K | -$41.3K | -674 | -52% |
|
|
VF
2
Virtu Financial
New York
| $14K | +$25.4K | +414 | New |
|
|
XT
3
XTX Topco
George Town,
Cayman Islands
| $12.1K | +$21.4K | +349 | New |
|
|
HF
4
HRT Financial
New York
| $11K | +$20.5K | +334 | New |
|
|
5
Two Sigma Investments
New York
| $10.5K | +$18.6K | +304 | New |
|
|
6
Jane Street
New York
| $8.69K | +$15.5K | +252 | New |
|
7
Geode Capital Management
Boston,
Massachusetts
| $4.97K | -$1.47K | -24 | -14% |
|
|
TSS
8
Two Sigma Securities
New York
| $4K | -$8.46K | -138 | -54% |
|
9
Morgan Stanley
New York
| $961 | – | – | – |
|
|
AFM
10
Anson Funds Management
Dallas,
Texas
| – | -$2.31M | -22,673 | Closed |
|
|
MG
11
Marex Group
London,
| – | -$25.5K | -250 | Closed |
|
|
12
Renaissance Technologies
New York
| – | -$13.5K | -132 | Closed |
|
MHUA Hedge Fund Activity: Q4 2024 in Review
9 of the 7,593 institutional investors tracked by Wall St. Rank reported a position in Meihua International Medical Technologies (MHUA) for Q4 2024, worth a combined $87.7K — down 97% from $2.53M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new MHUA positions and 3 closed out — a net gain of 2 holders — while 0 added to existing stakes and 3 trimmed.
The largest buyer was Virtu Financial, opening a new position worth an estimated $25.4K. The largest seller was Anson Funds Management, exiting entirely with an estimated $2.31M sold.
- 9 institutional investors held Meihua International Medical Technologies (MHUA) as of Q4 2024, up from 7 in Q3 2024.
- Funds reported $87.7K of Meihua International Medical Technologies stock for Q4 2024, down 97% quarter-over-quarter.
- 5 funds opened new Meihua International Medical Technologies positions in Q4 2024 and 3 closed out, a net change of +2 holders.
- The largest Meihua International Medical Technologies buyer in Q4 2024 was Virtu Financial, an estimated $25.4K added.
- The largest Meihua International Medical Technologies seller in Q4 2024 was Anson Funds Management, an estimated $2.31M sold.
Based on aggregated 13F filings for Q4 2024.